Literature DB >> 9601646

Genetic analysis of protein kinase B (AKT) in Drosophila.

B E Staveley1, L Ruel, J Jin, V Stambolic, F G Mastronardi, P Heitzler, J R Woodgett, A S Manoukian.   

Abstract

The decision between survival and death is an important aspect of cellular regulation during development and malignancy. Central to this regulation is the process of apoptosis, which is conserved in multicellular organisms [1]. A variety of signalling cascades have been implicated in modulation of apoptosis, including the phosphatidylinositol (Pl) 3-kinase pathway. Activation of Pl 3-kinase is protective, and inhibition of this lipid kinase enhances cell death under several conditions including deregulated expression of c-Myc, neurotrophin withdrawal and anoikis [2-7]. Recently, the protective effects of Pl 3-kinase have been linked to its activation of the pleckstrin homology (PH)-domain-containing protein kinase B (PKB or AKT) [8]. PKB/AKT was identified from an oncogene, v-akt, found in a rodent T-cell lymphoma [9]. To initiate a genetic analysis of PKB, we have isolated and characterized a Drosophila PKB/AKT mutant (termed Dakt1) that exhibits ectopic apoptosis during embryogenesis as judged by induction of membrane blebbing, DNA fragmentation and macrophage infiltration. Apoptosis caused by loss of Dakt function is rescued by caspase suppression but is distinct from the previously described reaper/grim/hid functions. These data implicate Dakt1 as a cell survival gene in Drosophila, consistent with cell protection studies in mammals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601646     DOI: 10.1016/s0960-9822(98)70231-3

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  47 in total

1.  Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria.

Authors:  S G Kennedy; E S Kandel; T K Cross; N Hay
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

Review 2.  Phosphatidylinositol 3' kinase signaling in mammary tumorigenesis.

Authors:  M P Scheid; J R Woodgett
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

3.  Stem Cells in Aging: Influence of Ontogenic, Genetic and Environmental Factors.

Authors:  Edmond J Yunis; Joaquin Zúñiga; Prasad S Koka; Zaheed Husain; Viviana Romero; Joel N H Stern; Masha Fridkis-Hareli
Journal:  J Stem Cells       Date:  2006

4.  dAkt kinase controls follicle cell size during Drosophila oogenesis.

Authors:  Valeria Cavaliere; Alessandra Donati; Anita Hsouna; Tien Hsu; Giuseppe Gargiulo
Journal:  Dev Dyn       Date:  2005-03       Impact factor: 3.780

5.  PDK1 regulates growth through Akt and S6K in Drosophila.

Authors:  F Rintelen; H Stocker; G Thomas; E Hafen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 6.  Disassembly of dying cells in diverse organisms.

Authors:  Rochelle Tixeira; Ivan K H Poon
Journal:  Cell Mol Life Sci       Date:  2018-10-13       Impact factor: 9.261

7.  The antibacterial arm of the drosophila innate immune response requires an IkappaB kinase.

Authors:  Y Lu; L P Wu; K V Anderson
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

8.  A genetic screen for dominant modifiers of a small-wing phenotype in Drosophila melanogaster identifies proteins involved in splicing and translation.

Authors:  Carmen M A Coelho; Benjamin Kolevski; Cherryl D Walker; Irene Lavagi; Thomas Shaw; Anselm Ebert; Sally J Leevers; Steven J Marygold
Journal:  Genetics       Date:  2005-07-05       Impact factor: 4.562

9.  Dynamic switch of negative feedback regulation in Drosophila Akt-TOR signaling.

Authors:  Lutz Kockel; Kimberly S Kerr; Michael Melnick; Katja Brückner; Matthias Hebrok; Norbert Perrimon
Journal:  PLoS Genet       Date:  2010-06-17       Impact factor: 5.917

10.  Akt phosphorylates both Tsc1 and Tsc2 in Drosophila, but neither phosphorylation is required for normal animal growth.

Authors:  Sibylle Schleich; Aurelio A Teleman
Journal:  PLoS One       Date:  2009-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.